Instructions for Pumpan oral drops, dropper bottle 50 ml
Composition
active ingredients: 100 ml of the preparation contains: Crataegus D1 20 ml, Arnica D6 10 ml, Kalium carbonicum D6 10 ml, Digitalis D12 10 ml, Convallaria D12 10 ml;
excipient: ethanol 43% (m/m).
1 ml of solution contains 25 drops.
Dosage form
Oral drops.
Main physicochemical properties: transparent yellowish to reddish-yellow liquid.
Pharmacotherapeutic group
A complex homeopathic remedy.
Pharmacological properties
Pharmacodynamics
The drug exhibits antianginal, metabolic, cardiotonic and antihypertensive effects. Reduces adrenergic innervation, has antiarrhythmic, mild diuretic, antioxidant and cardioprotective effects. Improves lipid metabolism (cholesterol, β-lipoprotein levels). Affects the rheological properties of blood, helps reduce plasma coagulation properties and normalizes fibrinogen levels and prothrombin index. The drug normalizes blood circulation, metabolic processes and nutrition of the heart muscle, contractile and pumping function of the myocardium, helps normalize elevated blood pressure, strengthens vascular walls and has an antisclerotic effect.
In complex treatment, Pumpan® reduces the frequency and intensity of angina attacks, prevents further development and exacerbation of heart disease. Due to the complex action, the inclusion of Pumpan® in basic cardiovascular therapy allows you to reduce the intake or doses of other cardiovascular drugs (nitrates, β-blockers, calcium antagonists). In patients with unstable angina, including those refractory to basic therapy, the inclusion of Pumpan® in complex treatment helps stabilize the patient's condition.
Pharmacokinetics
Not studied.
Indication
Neurocirculatory dystonia; in the complex treatment of chronic ischemic heart disease, arterial hypertension, dystrophic changes in the myocardium, heart rhythm disorders, heart failure.
Contraindication
Hypersensitivity to the active substances, to plants of the Asteraceae family (such as chamomile, calendula, chrysanthemum) or to the excipient of the drug.
Interaction with other medicinal products and other types of interactions
There is currently no information regarding the drug's interactions with other medications.
When using Pumpan® with other cardiovascular drugs, the intake or dose of basic therapy drugs may be reduced, but only under the supervision of a physician. It is recommended to observe a 20-minute break between taking the drugs.
An unhealthy lifestyle, the use of stimulants, and an unhealthy diet can negatively affect the effectiveness of homeopathic medicines.
Application features
In case of arrhythmias, the drug should not be taken without consulting a doctor, as Pumpan may reduce ectopic cardiac activity (supraventricular and ventricular extrasystoles), and some patients may sometimes experience an increase in supraventricular and ventricular extrasystoles.
Pumpan oral drops should not be used in patients with alcohol dependence, as one dose of the drug contains 160 mg of alcohol.
The alcohol content should also be taken into account when using the drug in pregnant women, breastfeeding women, children and patients with a high risk of liver disease and the risk of epileptic seizures.
At the beginning of treatment with the drug, existing symptoms of the disease may temporarily worsen (primary reaction). This reaction is usually not harmful. If the symptoms do not disappear, the drug should be discontinued. After the primary reaction has disappeared, the drug can be used again. If the symptoms worsen again, the drug should be discontinued.
Long-term treatment with homeopathic medicines should be supervised by a doctor experienced in the use of homeopathic medicines, as symptoms may occur that are not listed in the instructions for medical use.
Since Pumpan contains herbal and other natural ingredients, a slight change in the taste, transparency, or color of the solution may occur during storage, which does not lead to a decrease in the quality and effectiveness of the drug.
Ability to influence reaction speed when driving vehicles or other mechanisms
The drug has no or negligible influence on the ability to drive and use machines.
Use during pregnancy or breastfeeding
There are no data on the use of the drug during pregnancy or breastfeeding. There is no evidence of any risk of taking the drug during pregnancy or breastfeeding, therefore it is recommended to use the drug during this period with caution, only in cases where, in the opinion of the doctor, the expected benefit to the mother outweighs the potential risk to the fetus/child.
There are no data on the effect of the drug on reproductive function.
Method of administration and doses
At the beginning of treatment, as well as in cases requiring rapid relief of symptoms, it is recommended to take the drug every half hour to an hour up to 8 times a day until the condition improves, but not more than 3 days. After the condition improves, the frequency of administration should be reduced to 2-3 times a day.
To achieve maximum effect, it is recommended to take PumpanÒ between meals (30 minutes before or 1 hour after a meal), holding the drug in the mouth for some time before swallowing.
The duration of the treatment course is 2-3 months. When the condition stabilizes, it is possible to switch to 1-2 one-time maintenance doses.
Children
The use of Pumpan® oral drops in children under 12 years of age is not recommended due to insufficient data.
The use of Pumpan® oral drops in children aged 12 years and older is not recommended for therapeutic indications such as heart failure, arterial hypertension and ischemic heart disease due to insufficient data.
Overdose
No cases of overdose have been registered.
Adverse reactions
In rare cases, allergic reactions may occur in individuals with hypersensitivity to any component of the drug.
An increase in tachycardia phases and very rarely, mainly at night, an increase in bradycardia phases have been observed. There are insufficient data to conclude on the frequency of adverse reactions.
Expiration date
5 years. Do not use the drug after the expiration date indicated on the package.
Storage conditions
Store the medicine in a tightly closed bottle in the original cardboard packaging at a temperature not exceeding 30 °C, out of the reach of children.
Packaging
20 ml or 50 ml or 100 ml in dark glass dropper bottles, in a cardboard box.
Vacation category
Without a prescription.
Producer
Richard Bittner AG.
Location of the manufacturer and its business address
Ossiacherstrasse 7, A-9560 Feldkirchen, Austria.
